China
PharmCube, founded in 2013, is a China-based data and media company specializing in the pharmaceutical sector. The company aims to revolutionize the industry by providing a comprehensive data intelligence platform to streamline operations across the pharmaceutical chain. With its unique positioning, PharmCube has garnered a user base exceeding 100,000 professionals, establishing itself as a significant player in the field.
The company's platform monitors drug data on a global scale, encompassing countries like the United States, European Union, and Japan. By creating a robust data framework, it facilitates the entire spectrum of data handling—from collection and cleaning to mining and prediction. Leveraging machine learning, PharmCube is evolving its platform's capabilities to enhance efficiency and agility.
Their last investment round in November 2021 saw a significant infusion of CNY100.00M from investors like Apricot Capital and Wind. This solid financial backing supports PharmCube's ambition to lead the pharmaceutical data industry as the central connectivity and innovations hub.
